Stockreport

Trevena Announces Preclinical TRV045 Data Providing Insight Into Novel Mechanism of Analgesic Effect in Chronic Neuropathic Pain Model and Demonstrating Statistically Significant Anti-Seiz...

Trevena, Inc.  (TRVN) 
Last trevena, inc. earnings: 3/12 07:01 am Check Earnings Report
US:NASDAQ Investor Relations: investors.trevena.com/investor-relations
PDF TRV045 demonstrates statistically significant, dose-dependent increase in measures of seizure threshold and shows seizure protection in validated preclinical models T [Read more]